Page last updated: 2024-09-05

sb 203580 and naringin

sb 203580 has been researched along with naringin in 3 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(naringin)
Trials
(naringin)
Recent Studies (post-2010) (naringin)
3,48941,13792525639

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)naringin (IC50)
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)7.6785
AromataseHomo sapiens (human)5

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, H; Huang, R; Li, S; Wu, K; You, Q1
Chen, J; Guo, R; Huang, R; Li, S; Tian, L; Wu, K; Yan, H; You, Q1
Aroui, S; Chtourou, Y; Fetoui, H; Kenani, A; Laajimi, A; Meunier, AC; Najlaoui, F1

Other Studies

3 other study(ies) available for sb 203580 and naringin

ArticleYear
Naringin inhibits high glucose-induced cardiomyocyte apoptosis by attenuating mitochondrial dysfunction and modulating the activation of the p38 signaling pathway.
    International journal of molecular medicine, 2013, Volume: 32, Issue:2

    Topics: Animals; Apoptosis; Cell Line; Flavanones; Glucose; Imidazoles; Matrix Metalloproteinases; Mitochondria, Heart; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Signal Transduction

2013
Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
    Basic & clinical pharmacology & toxicology, 2014, Volume: 114, Issue:4

    Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Butadienes; Cell Line; Cell Survival; Enzyme Inhibitors; Flavanones; Fruit; Glucose; Hyperglycemia; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Pyridines; Rats; Reactive Oxygen Species

2014
Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:3

    Topics: Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Flavanones; Glioblastoma; Humans; Imidazoles; Immunoblotting; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2

2016